![Fabrice Chouraqui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 162 673 $ al 30/09/2026
Dr. Fabrice Chouraqui is an Independent Member-Governors Board at Orano Med Manufacturing SAS. He is on the Board of Directors at Orano Med Manufacturing SAS. Dr. Chouraqui was previously employed as a Chief Executive Officer & Executive Director by Pharming Group NV, a President by Novartis Pharmaceuticals Corp., and a Chief Executive Officer & Director by Cellarity Inc. He received his graduate degree from Universite Paris Cite, an MBA from INSEAD and a doctorate degree from Universite Paris Cite.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARMING GROUP NV 0,02 % | 31/03/2026 | 161.425 ( 0,02 % ) | 162 673 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Director Ejecutivo | 29/09/2026 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Presidente | 01/01/2019 |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Director Ejecutivo | 12/05/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
